EDSA: Strengthened Phase 3 ARDS Data Shows Significant Reduction in 28-Day Mortality

EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Updated Phase 3 ARDS Results Continue to Show Mortality Benefit On February 24, 2026, Edesa Biotech, Inc. (NASDAQ:EDSA) announced additional Pha ...
MedPage Today

ARDS Outcomes Better With Intravenous vs Inhaled Sedative

Inhaled sevoflurane significantly reduced ventilator-free days and 90-day survival versus IV propofol in moderate to severe ARDS. Inhaled volatile sedatives grew in popularity for prolonged use in ...
The American Journal of Managed Care

Sivelestat Lowers ARDS Risk, Mortality Following Cardiovascular Surgery

Sivelestat significantly reduced the incidence of postoperative ARDS, lowered 90-day mortality, and suppressed inflammatory biomarkers linked to lung injury.
Healio

ARDS plus pulmonary hypertension raises odds for mortality, longer hospital stay

Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension plus acute respiratory distress syndrome resulted in poor hospital outcomes. Odds for ...
Medscape

Does Inhaled Sevoflurane Sedation Affect ARDS Outcomes?

Inhaled sedation with sevoflurane in patients with moderate to severe acute respiratory distress syndrome (ARDS) resulted in fewer ventilator-free days at 28 days and lower 90-day survival than ...
Healio

Model predicts acute respiratory distress syndrome risk in patients with sepsis

Please provide your email address to receive an email when new articles are posted on . Thirteen factors were identified as potential predictors of acute respiratory distress syndrome. With these ...
Chicago Tribune

Researchers at Endeavor Health, Northwestern create AI tool to help identify dangerous respiratory syndrome

Researchers at Endeavor Health and Northwestern University have created an artificial intelligence-based tool to help doctors recognize an underdiagnosed, often fatal respiratory syndrome found in ...
News-Medical.Net

COVID-19 ARDS survivors face lasting disability and high late mortality, researchers report

In this single-center ambispective cohort of 283 Polish patients with COVID-19–related ARDS requiring invasive mechanical ventilation, cumulative mortality reached 44.5% at four years after ICU ...
Medscape

COVID Pandemic Drove Up Deaths From Respiratory Distress and Sepsis

Deaths from acute respiratory distress syndrome (ARDS) and sepsis spiked in the US during the COVID pandemic, and subsequently declined, according to new data presented at the American College of ...
Business Insider

Acute Respiratory Distress Syndrome (ARDS) Epidemiology and Patient Population to 2030 - Total Prevalent, Diagnosed, and Treated Cases

Dublin, July 14, 2020 (GLOBE NEWSWIRE) -- The "Acute Respiratory Distress Syndrome (ARDS) - Epidemiology Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. This report ...
Science Daily

Study provides new insights into deadly acute respiratory distress syndrome (ARDS)

Researchers may have discovered a mechanical explanation for instability observed in the lungs in cases of acute respiratory distress syndrome (ARDS), particularly in the aftermath of respiratory ...